Endothelial specific YY1 deletion restricts tumor angiogenesis and tumor growth
Abstract Angiogenesis is a physiological process for the formation of new blood vessels from the pre-existing vessels and it has a vital role in the survival and growth of neoplasms. During tumor angiogenesis, the activation of the gene transcriptions in vascular endothelial cells (ECs) plays an ess...
Guardado en:
Autores principales: | Huan Liu, Yikai Qiu, Xiuying Pei, Ramamurthy Chitteti, Rebbeca Steiner, Shuya Zhang, Zheng Gen Jin |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2020
|
Materias: | |
Acceso en línea: | https://doaj.org/article/9c4a57dd2aa34930a02d3214c650fdc3 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Endothelial deletion of SHP2 suppresses tumor angiogenesis and promotes vascular normalization
por: Zhiyong Xu, et al.
Publicado: (2021) -
Endothelial deletion of Ino80 disrupts coronary angiogenesis and causes congenital heart disease
por: Siyeon Rhee, et al.
Publicado: (2018) -
Endothelial-Rac1 is not required for tumor angiogenesis unless alphavbeta3-integrin is absent.
por: Gabriela D'Amico, et al.
Publicado: (2010) -
miRNA-27b targets vascular endothelial growth factor C to inhibit tumor progression and angiogenesis in colorectal cancer.
por: Jun Ye, et al.
Publicado: (2013) -
Multiscale modeling of tumor growth and angiogenesis: Evaluation of tumor-targeted therapy.
por: Sahar Jafari Nivlouei, et al.
Publicado: (2021)